# Dianthus Therapeutics, Inc. (DNTH): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/dnth for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $76.78 USD |
| Market Cap | $4.29B |
| P/E (TTM) | — |
| EPS (TTM) | −$4.15 |
| 52-Week Range | $32.28 – $117.88 |
| Dividend Yield (TTM) | — |

## Dividend

DNTH has no dividend payment history in our records.

## Frequently Asked Questions

### What does Dianthus Therapeutics, Inc. do?

Dianthus Therapeutics, Inc. (DNTH) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is DNTH's market cap?

Dianthus Therapeutics, Inc. (DNTH) has a market capitalization of approximately $4.29 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does DNTH pay a dividend?

No, Dianthus Therapeutics, Inc. (DNTH) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is DNTH profitable?

Dianthus Therapeutics, Inc. (DNTH) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has DNTH ever paid a dividend?

No. Dividend Data's records show no dividend payments from Dianthus Therapeutics, Inc. (DNTH). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/dnth
- Dividend history & safety: https://www.dividenddata.com/stocks/dnth/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/dnth/earnings
- Financial statements: https://www.dividenddata.com/stocks/dnth/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/dnth/valuation
- Peer comparison: https://www.dividenddata.com/stocks/dnth/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.